InChI=1S/C14H19N5O2/c1-5-19-13-10(8-16-19)12(18-17-9(3)4)11(7-15-13)14(20)21-6-2/h7-8H,5-6H2,1-4H3,(H,15,18) |
OPQRBXUBWHDHPQ-UHFFFAOYSA-N |
CCN1C2=NC=C(C(=C2C=N1)NN=C(C)C)C(=O)OCC |
|
phosphodiesterase IV inhibitor
An EC 3.1.4.53 (3',5'-cyclic-AMP phosphodiesterase) inhibitor that specifically blocks the action of phosphodiesterase IV.
alpha-secretase activator
An activator of alpha-secretase, one of the three endopeptidases that are specific for amyloid protein precursor and which have been identified based upon the region of the amyloid protein precursor which they cleave.
GABA agent
A substance, such as agonists, antagonists, degradation or uptake inhibitors, depleters, precursors, and modulators of receptor function, used for its pharmacological actions on GABAergic systems.
|
|
neuroprotective agent
Any compound that can be used for the treatment of neurodegenerative disorders.
antipsychotic agent
Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect.
anxiolytic drug
Anxiolytic drugs are agents that alleviate anxiety, tension, and anxiety disorders, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions.
antidepressant
Antidepressants are mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions.
GABA agent
A substance, such as agonists, antagonists, degradation or uptake inhibitors, depleters, precursors, and modulators of receptor function, used for its pharmacological actions on GABAergic systems.
|
|
View more via ChEBI Ontology
ethyl 1-ethyl-4-(2-isopropylidenehydrazino)-1H-pyrazolo[3,4-b]pyridine-5-carboxylate
|
étazolate
|
WHO MedNet
|
etazolate
|
WHO MedNet
|
etazolato
|
WHO MedNet
|
etazolatum
|
WHO MedNet
|
1-ethyl-4-(2-propan-2-ylidenehydrazinyl)-5-pyrazolo[3,4-b]pyridinecarboxylic acid ethyl ester
|
LINCS
|
1H-pyrazolo(3,4-b)pyridine-5-carboxylic acid, 1-ethyl-4-((1-methylethylidene)hydrazino)-, ethyl ester
|
SUBMITTER
|
EHT-0202
|
ChEBI
|
ethyl 1-ethyl-4-(2-isopropylidenehydrazino)pyrazolo[3,4-b]pyridine-5-carboxylate
|
SUBMITTER
|
ethyl 1-ethyl-4-(2-propan-2-ylidenehydrazinyl)pyrazolo[3,4-b]pyridine-5-carboxylate
|
SUBMITTER
|
ethyl 1-ethyl-4-(2-propan-2-ylidenehydrazinyl)pyrazolo[4,5-e]pyridine-5-carboxylate
|
SUBMITTER
|
ethyl 1-ethyl-4-[2-(1-methylethylidene)hydrazino]-1H-pyrazolo[3,4-b]pyridine-5-carboxylate
|
SUBMITTER
|
SQ-20,009
|
ChEBI
|
51022-77-6
|
CAS Registry Number
|
ChemIDplus
|
548872
|
Reaxys Registry Number
|
Reaxys
|
18397369
|
PubMed citation
|
SUBMITTER
|
20223232
|
PubMed citation
|
Europe PMC
|
22698578
|
PubMed citation
|
Europe PMC
|
23178198
|
PubMed citation
|
Europe PMC
|
23384434
|
PubMed citation
|
Europe PMC
|
23926692
|
PubMed citation
|
Europe PMC
|
23974048
|
PubMed citation
|
Europe PMC
|
24434771
|
PubMed citation
|
Europe PMC
|
24705918
|
PubMed citation
|
Europe PMC
|
25120105
|
PubMed citation
|
Europe PMC
|
25136630
|
PubMed citation
|
Europe PMC
|
27988361
|
PubMed citation
|
Europe PMC
|
449623
|
PubMed citation
|
SUBMITTER
|
6131949
|
PubMed citation
|
Europe PMC
|
6132997
|
PubMed citation
|
SUBMITTER
|
6991258
|
PubMed citation
|
Europe PMC
|
|